Pharmacology of ezetimibe

European Heart Journal, Supplement

Volumn 4, Issue J, 2002, Pages

  Van Heek, M ^a   Davis, H ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Biliary cholesterol; Cholesterol absorption inhibitor; Cholesterol lowering drugs; Ezetimibe; LDL cholesterol

Indexed keywords

1,4 BIS(4 METHOXYPHENYL) 3 (3 PHENYLPROPYL) 2 AZETIDINONE; ATORVASTATIN; CAMPESTEROL; CHOLESTEROL; DIGOXIN; ETHINYLESTRADIOL; EZETIMIBE; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; GLIPIZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEVONORGESTREL; MEVINOLIN; PRAVASTATIN; SIMVASTATIN; SITOSTEROL; WARFARIN;

ABSORPTION; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0036895375     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90076-3     Document Type: Review

References (25)

1. Salisbury BG, Davis HR, Burrier RE, Burnett DA, Bowkow G, Caplen MA, et al. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461. Atherosclerosis 1995; 115: 45-63.
2. van Heek M, France CF, Compton DS, et al. In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther 1997; 283: 157-63.
3. Rosenblum SB, Huynh T, Afonso A, et al. Discovery of 1-(4-fluorophenyl)-(3R)-[3-(4-fluorophenyl)-(3S)-hydroxypropyl]-(4S)- (4-hydroxyphenyl)-2-azetidinone (SCH 58235): A designed, potent, orally active inhibitor of cholesterol absorption. J Med Chem 1998; 41: 973-80.
4. Bays HE, Moore PB, Drehobl MA, et al. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: Pooled analysis of two phase II studies. Clin Ther 2001; 23: 1209-30.
5. van Heek M, Farley C, Compton DS, Hoos L, Davis HR. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 2001; 134: 409-17.
6. Davis HR Jr, Compton DS, Hoos L, Tetzloff G. Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in apoE knockout mice. Arterioscler Thromb Vasc Biol 2001; 21: 2032-8.
7. Altmann SW, Davis HR Jr, et al. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochim Biophys Acta 2002; 30: 77-93.
8. van Heek M, Austin TM, Farley C, Cook JA, Tetzloff GG, Davis HR. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. Diabetes 2001; 50: 1330-5.
9. van Heek M, Compton DS, Davis HR. The cholesterol absorption inhibitor, ezetimibe, decreases diet-induced hypercholesterolemia in monkeys. Eur J Pharmacol 2001; 415: 79-84.
10. Davis HR Jr, Pula KK, Alton KB, Burrier RE, Watkins RW. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs. Metabolism 2001; 50: 1234-41.
11. von Bergmann K, Salen G, Lutjohann D, Musliner T, Musser B. Ezetimibe effectively reduces serum plant sterols in patients with sitosterolemia. Atherosclerosis Supplements 2002; 3: 232.
12. Knopp R, Bays H, Manion C. Effect of ezetimibe on serum concentrations of lipid-soluble vitamins. Atherosclerosis Supplements 2001; 2: 90.
13. van Heek M, Farley C, Compton DS, et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol 2000; 129: 1748-54.
14. Patrick JE, Kosoglou T, Stauber KL, et al. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects. Drug Metab Dispos 2002; 30: 430-7.
15. Keung A, Kosoglou T, Statkevich P. Ezetimibe does not affect the pharmacokinetics of oral contraceptives. Clin Pharmacol Ther 2001; 69: 55.
16. Bauer K, Kosoglou T, Statkevich P. Ezetimibe does not affect the pharmacokinetics or pharmacodynamics of warfarin. Clin Pharmacol Ther 2001; 69: 5.
17. Kosoglou T, Statkevich P, Bauer K, et al. Ezetimibe does not affect the pharmacokinetics and pharmacodynamics of digoxin. AAPS PharmSci 2001 Annual Meeting Supplement 2001:3(3). Available from http://www.aapspharmaceutica.com/search/abstract.view.asp?id=290.
18. Reyderman L, Kosoglou T, Maxwell S. Lack of pharmacokinetic interaction between ezetimibe and fenofibrate. AAPS PharmSci 2001 Annual Meeting Supplement 2001:3(3). Available from http://www.aapspharmaceutica.com/search/abstract.view.asp?id=366.
19. Reyderman L, Kosoglou T, Statkevich P. Assessment of a multiple-dose drug interaction between ezetimibe and gemfibrozil. Presented at the XIVth International Symposium on Drugs Affecting Lipid Metabolism, New York, NY, 10-13 September 2001.
20. Reyderman L, Kosoglou T, Statkevich P. No pharmacokinetic drug interaction between ezetimibe and lovastatin. Clin Pharmacol Ther 2001; 69: 67.
21. Reyderman L, Statkevich P, Kosoglou T. No pharmacokinetic interaction between ezetimibe and either cerivastatin or fluvastatin. AAPS PharmSci 2001 Annual Meeting Supplement 2001:3(3). Available from http://www.aapspharmaceutica.com/search/abstract.view.asp?id=371.
22. Statkevich P, Reyderman L, Kosoglou T. Ezetimibe does not affect the pharmacokinetics and pharmacodynamics of glipizide. Clin Pharmacol Ther 2001; 69: 68.
23. Zhu Y, Statkevich P, Kosoglou T. Lack of a pharmacokinetic interaction between ezetimibe and atorvastatin. Clin Pharmacol Ther 2001; 69: 68.
24. Kosoglou T, Meyer I, Veltri E et al. Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor, ezetimibe, and simvastatin. Br J Clin Pharmacol 2002; 54: 309-319.
25. Sudhop T, Lutjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation 2002; 106: 1943-1948.